These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6977973)

  • 21. Fenofibrate inhibits thrombogenic and fibrinolytic factors expression in adipose tissue of atherosclerotic rabbits.
    Zhao SP; Li J; Xu Z; Wu J; Li Q; Ye H
    Clin Chim Acta; 2004 Nov; 349(1-2):81-6. PubMed ID: 15469859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fenofibrate reduces atherogenesis in ApoE*3Leiden mice: evidence for multiple antiatherogenic effects besides lowering plasma cholesterol.
    Kooistra T; Verschuren L; de Vries-van der Weij J; Koenig W; Toet K; Princen HM; Kleemann R
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2322-30. PubMed ID: 16873727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of fenofibrate on serum paraoxonase activity and inflammatory markers in patients with combined hyperlipidemia.
    Yesilbursa D; Serdar A; Saltan Y; Serdar Z; Heper Y; Guclu S; Cordan J
    Kardiol Pol; 2005 Jun; 62(6):526-30. PubMed ID: 16123850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are the lipid-modifying effects of fibrates mediated by alterations in plasma lipid transfer activity?
    Lewis GF
    Clin Sci (Lond); 2006 Sep; 111(3):185-7. PubMed ID: 16761953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lecithin: cholesterol acyltransfer, dyslipoproteinaemia and membrane lipids in uraemia.
    Gillett MP; Obineche EN; El-Rokhaimi M; Lakhani MS; Abdulle A; Sulaiman M
    J Nephrol; 2001; 14(6):472-80. PubMed ID: 11783603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fenofibrate reduces tumor necrosis factor-alpha serum concentration and adipocyte secretion of hypercholesterolemic rabbits.
    Zhao SP; Wu J
    Clin Chim Acta; 2004 Sep; 347(1-2):145-50. PubMed ID: 15313152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of carbohydrate and lipid metabolism in cases of hyperlipidemia and coronary heart disease. II. Preliminary observations on plasma lecithin cholesterol acyl transferase.
    Liu BW; Liu WZ; Wu ZF; Zhang RJ; Zhang Rongjue
    Chin Med J (Engl); 1979 Dec; 92(12):822-6. PubMed ID: 117986
    [No Abstract]   [Full Text] [Related]  

  • 28. Individual and combined effects of peroxisome proliferator-activated receptor and {gamma} agonists, fenofibrate and rosiglitazone, on biomarkers of lipid and glucose metabolism in healthy nondiabetic volunteers.
    Wagner JA; Larson PJ; Weiss S; Miller JL; Doebber TW; Wu MS; Moller DE; Gottesdiener KM
    J Clin Pharmacol; 2005 May; 45(5):504-13. PubMed ID: 15831773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fenofibrate decreases plasma fibrinogen, improves lipid profile, and reduces uricemia.
    de la Serna G; Cadarso C
    Clin Pharmacol Ther; 1999 Aug; 66(2):166-72. PubMed ID: 10460070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacokinetics of fenofibrate in man (author's transl)].
    Harvengt C; Desager JP
    Nouv Presse Med; 1980 Dec; 9(49):3725-7. PubMed ID: 7208337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of dietary phytosterols plus niacin or fenofibrate: effects on lipid profile and atherosclerosis in apo E-KO mice.
    Yeganeh B; Moshtaghi-Kashanian GR; Declercq V; Moghadasian MH
    J Nutr Biochem; 2005 Apr; 16(4):222-8. PubMed ID: 15808326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy of bezafibrate and fenofibrate on elevated blood lipids in HLP type IIa, IIb and IV].
    Schwartzkopff W; Luley C; Scheffler W; Lehmann-Leo W; Schilling A; Wegscheider K
    Med Welt; 1982 Apr; 33(17):631-7. PubMed ID: 7098826
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of propranolol treatment on total cholesterol, HDL cholesterol, triglycerides. Postheparin lipolytic activity and lecithin:cholesterol acyltransferase in hypertensive individuals.
    Schauer I; Schauer U; Rühling K; Thielmann K
    Artery; 1980; 8(2):146-50. PubMed ID: 7458680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fenofibrate: treatment of hyperlipidemia and beyond.
    Rosenson RS
    Expert Rev Cardiovasc Ther; 2008 Nov; 6(10):1319-30. PubMed ID: 19018684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in serum lipoprotein lipids and their fatty acid compositions and lipid peroxidation in growing rats fed soybean protein versus casein with or without cholesterol.
    Madani S; Frenoux JM; Prost J; Belleville J
    Nutrition; 2004 Jun; 20(6):554-63. PubMed ID: 15165619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Activity of the main plasma enzymes of lipid metabolism in diabetic retinopathies].
    Gol'tseva SV; Mkhitarian LS
    Oftalmol Zh; 1981; 36(7):418-20. PubMed ID: 7335260
    [No Abstract]   [Full Text] [Related]  

  • 37. [Seasonal changes of lecithin cholesterol acyltransferase in blood plasma].
    Schauer UJ; Schauer I; Thielmann K
    Z Med Lab Diagn; 1983; 24(3):173-5. PubMed ID: 6613250
    [No Abstract]   [Full Text] [Related]  

  • 38. [Lecithin-cholesterol acyltransferase activity and lipid composition of high density lipoprotein subfractions in hyperalphalipoproteinemia].
    Ozerova IN; Torkhovskaia TI; Polesskiĭ VA; Gerasimova EN
    Vopr Med Khim; 1980; 26(3):365-70. PubMed ID: 7456368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of selenium on lipids and some lipid metabolising enzymes in DMBA induced mammary tumor rats.
    Chidambaram N; Baradarajan A
    Cancer Biochem Biophys; 1995 Jun; 15(1):41-7. PubMed ID: 8536219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effects of statin and fibrate on nitric oxide bioactivity and matrix metalloproteinase in hyperlipidemia.
    Koh KK; Ahn JY; Jin DK; Han SH; Kim HS; Choi IS; Ahn TH; Shin EK; Jeong EM
    Int J Cardiol; 2004 Nov; 97(2):239-44. PubMed ID: 15458690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.